Dierk Scheinert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dierk scheinert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dierk Scheinert Today - Breaking & Trending Today

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started – Padovanews

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

United States , University Hospital , Thomas Zeller , Nassan Malyar , Dierk Scheinert , Ulf Teichgr , Concept Medical Inc , University Hospitals Jena , Drug Administration , Drug Coated Balloon , Standard Angioplasty , Infrapopliteal Occlusions , Arterial Disease , Principal Investigator , Magic Touch , Plain Old Balloon Angioplasty , Breakthrough Device , Coated Balloon , Breakthrough Device Designation ,

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

Munster, [Germany], July 30 (ANI/PRNewswire): LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug-Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease) has already enrolled 15 patients, which is encouraging as the Company looks to take a leap in the peripheral artery disease (PAD) treatment. Initiated by the University Hospitals Jena and Leipzig in Germany and led by Principal Investigator (PI) Prof. Dr Ulf Teichgraber alongside Co-PI Prof. Thomas Zeller and Prof. Dierk Scheinert, LIMES is a prospective, multicentre, randomized controlled trial (RCT) which is designed and aimed to evaluate Magic Touch - PTA 0.014" and 0.018" (Concept Medical Inc) versus POBA (Plain Old Balloon Angioplasty) in a head-to-head comparison (1:1). The trial kicked off with the index patient enrolled on 31st March 2022 by PD Dr Nassan Malyar at the Universit ....

United States , Thomas Zeller , Nassan Malyar , Ulf Teichgraber , Dierk Scheinert , University Hospital Munster , Concept Medical Inc , University Hospitals Jena , Drug Administration , Drug Coated Balloon , Standard Angioplasty , Infrapopliteal Occlusions , Arterial Disease , Principal Investigator , Magic Touch , Plain Old Balloon Angioplasty , Breakthrough Device , Coated Balloon , Breakthrough Device Designation , Uly 30 Ani Prnewswire Limes Prospective Multi Center Randomized Controlled Trial To Evaluate The Safety And Efficacy Of Sirolimus Drug Coated Balloon Versus Standard Angioplasty For Treatment Infrapopliteal Occlusions In Patients With Peripheral Arterial Disease Has Already Enrolled 15 , Hich Is Encouraging As The Company Looks To Takea Leap In Peripheral Artery Disease Pad Treatment Initiated By University Hospitals Jena And Leipzig Germany Led Principal Investigator Pi Prof Dr Ulf Teichgraber Alongside Co Thomas Zeller Dierk Scheinert , Imes Isa Prospective , Andomized Controlled Trial Rct Which Is Designed And Aimed To Evaluate Magic Touch Pta 0 014 Quot 018 Concept Medical Inc Versus Poba Plain Old Balloon Angioplasty Ina Head Comparison 1 The Kicked Off With Index Patient Enrolled On 31st March 2022 By Pd Dr Nassan Malyar At University Hospital Munster In Germany Limes Set Enrol 230 Patients , Andomized In 1 Magic Touch Pta Poba Fashion Currently 19 Centres Across Germany And Austria The Patient Population Will Include Patients Presenting With Documented Chronic Critical Limb Ischemia Cli Target Defined As Rutherford Clinical Category Rcc 4 , O Lesion Length Limitation And No In Number Of Used Devices Follow Up Will Be Per House Visits At 30 Days , 4 And 36 Months The Rct Will Measure Efficacy Of Sirolimus Coated Balloons Ina Complex Setting Clti Pad Segment Located Below P3 Popliteal Artery To Tibiotalar Joint Against Current Standard Care ,

17th Annual Leipzig Interventional Course (LINC) will 'Connect the World' with a Virtual Format


17th Annual Leipzig Interventional Course (LINC) will ‘Connect the World’ with a Virtual Format
Share Article
Premier interdisciplinary course on endovascular interventions will deliver expanded education, including a record number of live cases
“No matter the circumstances, LINC remains committed to providing a platform for the interdisciplinary exchange of the latest scientific data and technical aspects of endovascular interventions for specialists,” said Dierk Scheinert, MD, founder and course director, LINC.
MALVERN, Pa. (PRWEB)
January 13, 2021
HMP Global, a leading healthcare event and education company, today announced that the 17th installation of the Leipzig Interventional Course (LINC) will convene virtually January 25-29, 2021. The online event will feature a record 17 live case transmission centers from around the world, streaming more than 40 interventional cases, data ....

United States , Kenneth Rosenfield , Brian Derubertis , Thomas Zeller , Weiguo Fu , Francesco Liistro , Michael Lichtenberg , Dierk Scheinert , Sabine Steiner , Andrej Schmidt , Ehrin Armstrong , Kelly Mccurdy , Koen Deloose , Marianne Brodmann , Psych Congress , Leipzig Interventional Course , New Data , Innovative Concepts , Femoral Arteries , Healthcare Made Practical , North America , Advanced Wound Care , Press Release , ஒன்றுபட்டது மாநிலங்களில் , கெநெத் ரோசன்ஃபீல்ட் , பிரையன் தேறுபேர்ட்டிஸ் ,